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Unique Pt5 metallacycle: [PtIICl(pyrrolidinedithiocarbamate)]5†‡
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The neutral complex [PtCl(PyDT)]5 (PyDT = (CH2)4NCS2-)
represents the first example of a Pt5 metallacycle. This unique
architecture based on chiral S-bridged PtII monomers was
prepared by thermal degradation of the reaction product of
PtCl2 and a pyrrolidinedithioester.
Dithiocarbamate complexes of transition metals have been widely
studied,1 focusing mainly on their antitumoral properties and
flexible possibilities for molecular architectures. Due to their
extremely versatile and robust motif, dithiocarbamates have been
utilized formetal-directed self-assembly,2 andmore recently for the
stabilization of gold nanoparticles.3 They are well-known chemo-
protective agents against heavy metal intoxication,4 particularly
against cisplatin,5 the most prolific antitumoral drug. Recent ten-
dencies aiming to reduce the toxicity of antitumoral drugs require
the design of new molecules based on either nitrogen (analogue
to cisplatin) or sulfur donor atoms (as carbamates).6 Interesting
results were obtained with PtII, PdII and AuIII compounds with
ethylsarcosinedithio- and dimethyldithiocarbamates as ligands.7
Complexes containing pyrrolidinedithiocarbamate (PyDT) are
under investigation in order to develop potential antitumoral
drugs, with Ru(III) complexes being the most active.8
The versatility of dithiocarbamates for molecular architectures
lies in their ability to coordinate metals in different modes (Chart
1): as (i) monodentate ligands, involving one of the sulfur atoms,
as (ii) bidentate ligands, with both donor S atoms coordinated to
the same metal (as chelate) or to different (as bridging S) metals,
and combining both modes, as (iii) tridentate and even (iv) as
tetradentate ligands (Chart 1). The combination of such flexible
ligands with the binding possibilities of transition metals results
in a multitude of mono- and multinuclear, discrete and polymeric
constructs.9
Here, we report the first example of a Pt5 metallacycle, extending
the existing series of platinum (Pt2, Pt3, Pt4 andPt6)metallacycles.10
Examples of discretemetallapentagons involving transitionmetals
aDipartamento di Science Chimiche, Universita di Padova, 35131, Padova,
Italy. E-mail: diego.montagner@unipd.it; Fax: +39 827-5161
bDepartamento de Quı´mica Inorga´nica, Instituto de Sı´ntesis Quı´mica y
Cata´lisis Homoge´nea (ISQCH), Universidad de Zaragoza- CSIC, 50009,
Zaragoza, Spain. E-mail: pablo.sanz@unizar.es; Fax: +34 976-761187
†Dedicated to Professor Bernhard Lippert on the occasion of his
retirement.
‡ Electronic supplementary information (ESI) available: Instrumentation,
synthesis procedures and TG-DTA studies. CCDC reference numbers
823484 (2) and 823485 (3). For ESI and crystallographic data in CIF
or other electronic format see DOI: 10.1039/c1dt11475a
Chart 1
are not as common as other metallastructures, such as triangles,
squares, hexagons or macrocycles.11
The reaction of PtCl2 with pyrrolidinedithioester (PyDTM)
yields [PtCl2(PyDTM)] (1), which after thermal degradation
(220 ◦C)6 produces [PtCl(PyDT)]5 (2) (PyDT = pyrrolidinedithio-
carbamate) (Scheme 1a). Crystals were grown by the slow evap-
oration of 2 in dichloroethane, crystallizing with two molecules
of solvent.§ Dithiocarbamate complexes of general formula
[MCl(RDT)]n can be stabilized by halogen (M = Pd; n = 2)12 or
sulfur (M = Pd, Pt; n = 2, 3)13 bridging ligands.
Scheme 1
The metallacyclic structure of complex 2 is assembled from
five chiral PtCl(PyDT) units (Fig. 1c). The PyDT moieties act as
tridentate ligands, both chelating Pt and bridging the platinum
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Fig. 1 Three different perspectives of complex 2: (a) detail of the chirality
of the monomer; (b) schematic view of the envelope conformation; (c)
molecular structure.
atom (Pt¢) of a vicinal monomer. Thus, the square planar
coordination of each PtII unit consists of three sulfur atoms, with
an additional chloride ligand occupying the fourth position. The
chirality of the monomer originates from the orientation of the
linked platinum atom (Pt¢) of a vicinal monomer, which can be
situated above (D) or below (K) the coordination plane of the
platinum atom of the monomer (Scheme 1b).
As shown in Fig. 1a, three of the monomers (Pt1, Pt2, and
Pt5) have identical chirality (K), whereas Pt3 and Pt4 are in the
enantiomeric D configuration. As complex 2 crystallizes in the
centrosymmetric space group P1¯, both absolute configurations
of complex 2 (K,K,K,D,D and D,D,D,K,K) are present in equal
amounts in the crystal lattice.
Distances and angles around the five platinum atoms are com-
piled in Table 1. In all cases, deviations from the best plane defined
by the platinum and four donor atoms do not exceed 0.04(2) A˚
(S38). Typical angle values for platinum are observed due to the
chelation of the dithiocarbamate species. The internal chelate S–
Pt–S angles are almost identical, ranging from 75.38(14)◦ (S37–
Pt3–S38) to 76.19(14)◦ (S47–Pt4–S48). Analogous Pt–Cl and Pt–
S bond distances and angles were found in the related species
[PtCl(S2CNEt2)(MeS2CNEt2)].14 The tridentate coordination of
the PyDT ligand (cf.Chart 1) results in slight differences regarding
the Pt–S bond lengths, depending on the coordinationmode of the
sulfur atoms: chelating-S or chelating-bridging-S. The distance
between PtII and the sulfur atom participating only in chelate
binding is almost unaltered for the five platinum atoms (from
Pt3–S38, 2.295(4) A˚ to Pt5–S58, 2.311(4) A˚), as also occurs
for Pt–Cl (from Pt5–Cl5, 2.307(4) A˚ to Pt4–Cl4, 2.332(4) A˚).
For the Pt–S distances involving chelating-bridging-S atoms, it
is observed that the chelating distance is significantly shorter
compared to the bridging distance (Pt1–S17, 2.305(4) A˚ and Pt2–
S17, 2.337(4) A˚; Pt2–S27, 2.286(4) A˚ and Pt3–S27, 2.318(4) A˚;
Pt3–S37, 2.296(4) A˚ and Pt4–S37, 2.309(4) A˚; Pt4–S47, 2.272(4)
A˚ and Pt5–S47, 2.302(4) A˚; Pt5–S57, 2.295(4) A˚ and Pt1–S57,
2.305(4) A˚). This is probably a consequence of the unusually
different hybridization assumed by both sulfur atoms. In the case
of thePt1monomer, the sp2-hybridizedS18 atomdisplays a shorter
bond length to C16 (1.670(17) A˚) in comparison to the C16–S17
distance (1.789(17) A˚) shown by the sp3 hybridized S17 atom, trans
to Cl1. This situation is analogous in the other four monomers
(C26–S27, 1.765(15) A˚ and C26–S28, 1.707(15) A˚; C36–S37,
1.778(14) A˚ and C36–S38, 1.711(14) A˚; C46–S47, 1.765(13) A˚
and C46–S48, 1.700(14) A˚; C56–S57, 1.758(15) A˚ and C56–S58,
1.720(15) A˚).
The core of the complex consists of an unsymmetrical (Pt–S)5
crown of the unusual type A25A25.15 In addition to the above-
described Pt–S distances and S–Pt–S angles of the platinum
coordination sphere (Table 1), the Pt–S–Pt angles are slightly
distorted from ideal sp3 hybridization (Pt1–S17–Pt2, 112.11(17)◦;
Pt2–S27–Pt3, 109.62(16)◦; Pt3–S37–Pt4, 113.84(16)◦; Pt4–S47–
Pt5, 115.84(15)◦; Pt5–S57–Pt1, 111.06(17)◦). The platinum atoms
within the crown adopt an envelope-like conformation, in which
Pt1, Pt2, Pt4 and Pt5 roughly lie on the same plane (maximum
deviation of 0.1382(3) A˚ for Pt5), Pt3 being out of the plane by
2.9803(17) A˚ (Fig. 1b). Pt–Pt distances between adjacent corners
within the crown are similar (Pt1–Pt2, 3.8511(14) A˚; Pt2–Pt3,
3.7627(15) A˚; Pt3–Pt4, 3.8586(16) A˚; Pt4–Pt5, 3.8760(13) A˚; Pt5–
Pt1, 3.7917(11) A˚). Likewise, the S–S distances in the crown are
within the same range (S17–S27, 3.490(5) A˚; S27–S37, 3.649(5)
A˚; S37–S47, 3.417(5) A˚; S47–S57, 3.376(5) A˚; S57–S17, 3.453(5)
A˚). The mutual dispositions (dihedral angles) of the PtII coordi-
nation planes are as follows (Pt2/Pt4, 10.9(1)◦; Pt3/Pt5, 19.5(1)◦;
Table 1 Selected bond distances (A˚) and angles (◦) in 2
Pt1–S17, 2.305(4) Pt2–S27, 2.286(4) Pt3–S37, 2.296(4) Pt4–S47, 2.272(4) Pt5–S57, 2.295(4)
Pt1–S18, 2.296(4) Pt2–S28, 2.302(4) Pt3–S38, 2.295(4) Pt4–S48, 2.310(4) Pt5–S58, 2.311(4)
Pt1–S57, 2.305(4) Pt2–S17, 2.337(4) Pt3–S27, 2.318(4) Pt4–S37, 2.309(4) Pt5–S47, 2.302(4)
Pt1–Cl1, 2.315(4) Pt2–Cl2, 2.311(5) Pt3–Cl3, 2.330(4) Pt4–Cl4, 2.332(4) Pt5–Cl5, 2.307(4)
S17–Pt1–S18, 76.09(15) S27–Pt2–S28, 75.76(15) S37–Pt3–S38, 75.38(14) S47–Pt4–S48, 76.19(14) S57–Pt5–S58, 75.61(13)
S17–Pt1–S57, 97.04(14) S27–Pt2–S17, 98.02(15) S37–Pt3–S27, 104.51(13) S47–Pt4–S37, 96.50(13) S57–Pt5–S47, 94.50(13)
S18–Pt1–Cl1, 93.63(17) S28–Pt2–Cl2 92.50(16) S38–Pt3–Cl3, 95.71(16) S48–Pt4–Cl4, 96.01(16) S58–Pt5–Cl5, 96.08(15)
S57–Pt1–Cl1, 93.24(16) S17–Pt2–Cl2, 93.69(16) S27–Pt3–Cl3, 84.43(15) S37–Pt4–Cl4, 91.26(16) S47–Pt5–Cl5, 93.82(15)
S18–Pt1–S57, 173.13(15) S28–Pt2–S17, 173.70(15) S38–Pt3–S27, 177.23(16) S37–Pt4–S48, 172.54(14) S47–Pt5–S58, 169.99(13)
S17–Pt1–Cl1, 169.72(16) S27–Pt2–Cl2, 168.11(16) S37–Pt3–Cl3, 171.05(15) S47–Pt4–Cl4, 172.12(15) S57–Pt5–Cl5, 171.68(15)















































Pt2–Pt4/Pt3–Pt5, 72.1(2)◦; Pt1/Pt2–Pt4, 83.3(2)◦; Pt1/Pt3–Pt5,
63.17(9)◦).
The reaction of complex 2 with different P- or S-donor
ligands results in facile cleavage of the PtII–S bridge, leading to
different mononuclear species, such as [PtCl(PyDT)(PPh3)] (3) or
[PtCl(PyDT)(DMSO)] (4) (ESI‡).
Crystals of 3 suitable for X-ray analysis were obtained by the
slow addition of n-pentane to a dichloromethane solution.¶ The
structure of complex 3 is somewhat related to that of themonomers
of 2, including the PyDT and chloride ligands, and a PPh3 group,
which formally substitutes the second bridged PyDT ligand (Fig.
2). Both S atoms of the PyDT ligand in 3 act only as chelates, thus
no sp3 hybridization is expected for the sulfur atoms, contrary to
the situation observed in 2. This is clearly observable in the C–S
distances, which are almost identical (C16–S17, 1.738(7) A˚; C16–
S18, 1.716(7) A˚). The distances and angles around Pt1 and within
the molecule are normal (ESI‡) and similar to related complexes,
such as [M(S2CNEt2)(PPh3)Cl] (M = Pd, Pt).16
Fig. 2 View of [PtCl(PyDT)(PPh3)] (3).
In conclusion, the self-assembly of five PtCl(PyDT) monomers
of different chirality results in a unique Pt5 metallacyclic structure,
[PtCl(PyDT)]5 (2), with two possible enantiomers (K,K,K,D,D and
D,D,D,K,K). With this PyDT chelating ligand, a pentamer is the
smallest possible construction, stabilizing the two different (sp2
and sp3) hybridizations of the S atoms. This work also extends
the existing examples of discrete PtII metallacycles, with potential
applications based on a dithiocarbamate-platinum tandem.
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